SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (20592)5/12/1998 10:39:00 AM
From: Hippieslayer  Respond to of 32384
 
looks like the deal will propel LGND over 20 sometime later this year or next year. Hey tony, wouldn't it be a riot of the SRGN FDA approval is delayed. It would be just LGND's luck.



To: tonyt who wrote (20592)5/12/1998 11:11:00 AM
From: dwc  Read Replies (5) | Respond to of 32384
 
But at LGND at 14, they get 50 cents a share. They must think its a good deal for LGND, too.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News